ScholarWorks@Hanyang University

Browsing by Park, WonAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 20 of 53

SCISCIESCOPUSKCI
A Clinical Trial and Extension Study of Infliximab in Korean Patients with Active Rheumatoid Arthritis despite Methotrexate TreatmentGo to Link

Kim, Jinhyun; Ryu, Heejung; Yoo, Dae-Hyun; Park, Sung-Hwan; Song, Gwan-Gyu; Park, Won; Cho, Chul-Soo; Song, Yeong-Wook

ArticleIssue Date2013CitationJournal of Korean Medical Science, v.28, no.12, pp 1716 - 1722Publisher대한의학회
SCISCIESCOPUS
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritisGo to Link

Yoo, Dae Hyun; Suh, Chang-Hee; Shim, Seung Cheol; Jeka, Slawomir; Cons-Molina, Francisco Fidencio; Hrycaj, Pawel; Wiland, Piotr; Lee, Eun Young; Medina-Rodriguez, Francisco G.; Shesternya, Pavel, et al.

ArticleIssue Date2017CitationAnnals of the Rheumatic Diseases, v.76, no.3, pp 566 - 570PublisherBMJ Publishing Group
SCISCIESCOPUS
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA studyGo to Link

Yoo, Dae Hyun; Racewicz, Artur; Brzezicki, Jan; Yatsyshyn, Roman; Arteaga, Edgardo Tobias; Baranauskaite, Asta; Abud-Mendoza, Carlos; Navarra, Sandra; Kadinov, Vladimir; Sariego, Irmgadt Goecke, et al.

ArticleIssue Date2016CitationArthritis Research & Therapy, v.18PublisherBioMed Central
SCISCIESCOPUS
A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA studyGo to Link

Bae, Sang-Cheol; Kim, Jinseok; Choe, Jung-Yoon; Park, Won; Lee, Sang-Heon; Park, Yong-Beom; Shim, Seung-Cheol; Lee, Shin-Seok; Sung, Yoon-Kyoung; Choi, Chan-Bum, et al.

ArticleIssue Date2017CitationAnnals of the Rheumatic Diseases, v.76, no.1, pp 65 - 71PublisherBMJ Publishing Group
SCISCIESCOPUS
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS studyGo to Link

Park, Won; Hrycaj, Pawel; Jeka, Slawomir; Kovalenko, Volodymyr; Lysenko, Grygorii; Miranda, Pedro; Mikazane, Helena; Gutierrez-Urena, Sergio; Lim, MieJin; Lee, Yeon-Ah, et al.

ArticleIssue Date2013CitationAnnals of the Rheumatic Diseases, v.72, no.10, pp 1605 - 1612PublisherBMJ Publishing Group
SCISCIESCOPUS
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA studyGo to Link

Yoo, Dae Hyun; Hrycaj, Pawel; Miranda, Pedro; Ramiterre, Edgar; Piotrowski, Mariusz; Shevchuk, Sergii; Kovalenko, Volodymyr; Prodanovic, Nenad; Abello-Banfi, Mauricio; Gutierrez-Urena, Sergio, et al.

ArticleIssue Date2013CitationAnnals of the Rheumatic Diseases, v.72, no.10, pp 1613 - 1620PublisherBMJ Publishing Group
A Randomized, Double-Blind, Phase 3 Equivalence Trial Comparing the Etanercept Biosimilar, HD203, with Etanercept (Enbrel (R)), in Combination with Methotrexate (MTX) in Patients with Rheumatoid Arthritis (RA)Go to Link

Bae, Sang-Cheol; Kim, Jinseok; Choe, Jung-Yoon; Park, Won; Lee, So-Ra; Ahn, Yongho; Seo, Yunjeong

ConferenceIssue Date2014Citation2014 ACR/ARHP Annual Meeting, pp.S1234PublisherWILEY-BLACKWELLPlaceUS; Boston, MA.
SCISCIESCOPUS
A RETROSPECTIVE ANALYSIS OF LONG TERM SAFETY UP TO FIVE YEARS OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITISGo to Link

Kim, Tae-Hwan; Lee, Shin-Seok; Park, Won; Song, Yeong Wook; Suh, Chang-Hee; Kim, Sookyoung; Lee, Youngnam; Yoo, DaeHyun

ArticleIssue Date2019CitationAnnals of the Rheumatic Diseases, v.78, pp 1159 - 1160PublisherBMJ Publishing Group
A Series of Double-Blind, Placebo-Controlled, Randomized, Multicenter, Phase 2 Studies to Evaluate the Efficacy, Safety, and Dose-Response Relationship of Orally Administered URC102, a Novel URAT1 Inhibitor, in Korean Patients with Gout

Jun, Jae-Bum; Lee, Howard; Suh, Chang-Hee; Lee, Chang Keun; Kim, Dong Wook; Choe, Jung-Yoon; Lee, Sang-Heon; Kim, Sang-Hyon; Hong, Seung-Jae; Bang, So-Young, et al.

ConferenceIssue Date2017Citation2017 ACR/ARHP Annual MeetingPublisherWILEYPlaceUS
SCIESCOPUS
Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal productGo to Link

Yoo, Dae Hyun; Oh, Choongseob; Hong, SeungSuh; Park, Won

ArticleIssue Date2015CitationExpert Review of Clinical Immunology, v.11, pp S15 - S24PublisherFuture Drugs Ltd.
SCIESCOPUSKCI
Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23Go to Linkopen access

Kim, Kyubo; Park, Hae Jin; Shin, Kyung Hwan; Kim, Jin Ho; Choi, Doo Ho; Park, Won; Ahn, Seung Do; Kim, Su Ssan; Kim, Dae Yong; Kim, Tae Hyun, et al.

ArticleIssue Date2018CitationCANCER RESEARCH AND TREATMENT, v.50, no.4, pp.1316 - 1323PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUSKCI
Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02)Go to Linkopen access

Kim, Jae Sik; Kim, Kyubo; Shin, Kyung Hwan; Kim, Jin Ho; Ahn, Seung Do; Kim, Su Ssan; Kim, Yong Bae; Chang, Jee Suk; Choi, Doo Ho; Park, Won, et al.

ArticleIssue Date2020CitationJOURNAL OF BREAST CANCER, v.23, no.2, pp.194 - 204PublisherKOREAN BREAST CANCER SOC
SCIESCOPUS
Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapyGo to Link

Chang, Ji Hyun; Shin, Kyung Hwan; Ahn, Seung Do; Park, Hae Jin; Chie, Eui Kyu; Kim, Jin Ho; Kim, Su Ssan; Kim, Yong Bae; Park, Won; Kim, Yeon-Joo, et al.

ArticleIssue Date2018CitationBREAST CANCER RESEARCH AND TREATMENT, v.169, no.3, pp.507 - 512PublisherSPRINGER
SCISCIESCOPUS
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS studyGo to Link

Park, Won; Yoo, Dae Hyun; Jaworski, Janusz; Brzezicki, Jan; Gnylorybov, Andriy; Kadinov, Vladimir; Goecke Sariego, Irmgadt; Abud-Mendoza, Carlos; Otero Escalante, William Jose; Kang, Seong Wook, et al.

ArticleIssue Date2016CitationArthritis Research & Therapy, v.18, pp 1 - 11PublisherBioMed Central
SCIESCOPUS
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trialGo to Linkopen access

Park, Won; Bozic-Majstorovic, Ljubinka; Milakovic, Dragana; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elias; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco Fidencio; Shesternya, Pavel; Miranda, Pedro; Medina-Rodriguez, Francisco G., et al.

ArticleIssue Date2018CitationMABS, v.10, no.6, pp.934 - 943PublisherTAYLOR & FRANCIS INC
SCIESCOPUS
Comparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy subjects: a randomized, double-blind, three-arm, parallel-group, single-dose, Phase I studyGo to Link

Park, Won; Lee, Sang Joon; Yun, Jihye; Yoo, Dae Hyun

ArticleIssue Date2015CitationExpert Review of Clinical Immunology, v.11, no.s1, pp S25 - S31PublisherFuture Drugs Ltd.
SCIESCOPUSKCI
Dose-Volume Analysis of Lung and Heart according to Respiration in Breast Cancer Patients Treated with Breast Conserving SurgeryGo to Link

Shim, Jae-Goo; Kim, Jeong-Koo; Park, Won; Seo, Jeong-Min; Hong, Chae-Sun; Song, Ki-Won; Lim, Cheong-Hwan; Jung, Hong-Ryang; Kim, Chan-Hyeong

ArticleIssue Date2012CitationJournal of Breast Cancer, v.15, no.1, pp 105 - 110Publisher한국유방암학회
SCIESCOPUS
Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid ArthritisGo to Linkopen access

Choi, In Ah; Lee, Sang Jin; Park, Won; Park, Sung Hwan; Shim, Seung-cheol; Baek, Han Joo; Yoo, Dae-Hyun; Kim, Hyun Ah; Lee, Soo Kon; Lee, Yun Jong, et al.

ArticleIssue Date2018CitationARCHIVES OF RHEUMATOLOGY, v.33, no.4, pp.389 - 394PublisherTURKISH LEAGUE AGAINST RHEUMATISM
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 WeeksGo to Link

Yoo, Dae-Hyun; Majstorovic, Ljubinka Bozic; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elias; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco; Miranda, Pedro; Shesternya, Pavel; Medina-Rodriguez, Francisco G.; Wiland, Piotr, et al.

ConferenceIssue Date2016Citation2016 ACR/ARHP Annual MeetingPublisherWILEYPlaceUS
SCISCIESCOPUS
Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension studyGo to Link

Yoo, Dae Hyun; Prodanovic, Nenad; Jaworski, Janusz; Miranda, Pedro; Ramiterre, Edgar; Lanzon, Allan; Baranauskaite, Asta; Wiland, Piotr; Abud-Mendoza, Carlos; Oparanov, Boycho, et al.

ArticleIssue Date2017CitationAnnals of the Rheumatic Diseases, v.76, no.2, pp 355 - 363PublisherBMJ Publishing Group
1 2 3
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어